Newsfeeds - Spark Newswire

1 minute read

NeuroPace Awarded Five-Year NIH Grant Funding Of $9.3M To Study RNS System In Patients With Lennox-Gastaut Syndrome

Today, 11:26 PM

NeuroPace, Inc., a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today announced that it has received a National Institutes of Health (NIH) grant through the Brain

NPCE

1 minute read

SVB Leerink Maintains Outperform on NeuroPace, Raises Price Target to $30

By Benzinga Newsdesk

Today, 11:26 PM

SVB Leerink analyst Danielle Antalffy maintains NeuroPace (NASDAQ:NPCE) with a Outperform and raises the price target from $25 to $30.

NPCE

1 minute read

NeuroPace Q1 Sales $11.20M Beat $10.99 Estimate

By Benzinga Newsdesk

Today, 11:26 PM

NeuroPace (NASDAQ:NPCE) reported quarterly sales of $11.20 million which beat the analyst consensus estimate of $10.99 by 101.91M percent.

NPCE

3 minute read

Earnings Scheduled For June 3, 2021

By Benzinga Insights

Today, 11:26 PM

Companies Reporting Before The Bell • Conn's (NASDAQ:CONN) is projected to report earnings for its first quarter. • Tuniu (NASDAQ:TOUR) is projected to report earnings for its first quarter.

ASAN

5 minute read

Uncategorized

58 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:26 PM

Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results.

AGEN

2 minute read

Uncategorized

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

By Shanthi Rexaline

Today, 11:26 PM

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.

ACRX